期刊文献+

恩替卡韦对映异构体的合成、表征及HPLC分析 被引量:2

Synthesis,characterization and HPLC analysis of enantiomer of entecavir
下载PDF
导出
摘要 手性控制是药物研究的重要组成部分。以保持手性骨架的碳环糖为原料,与2-氨基-6-苄氧基嘌呤缩合后,经过氨基保护、Dess-Martin氧化、亚甲基化、脱保护等6步反应,制得恩替卡韦对映异构体,总得率37%。通过二维核磁NOESY实验确定对映异构体绝对构型后,建立恩替卡韦与其对映异构体的HPLC分析方法,用于恩替卡韦原料药的手性质量控制。 Chiral contlol was an important constitute in pharmaceutical study. This article reports a synthetic method of enantiomer of entecavir, which was prepared via 6 steps including condensation, amino protection, Dess-Martin oxidation, methylene and deprotection from carbocyclic sugar with corresponding chiral skeleton and 2-amino-6-benzyloxy purine as materials, with total yield 37%. HPLC analysis method was estanlishod to be applied in chiral control for entecavir API after determination for absolute configuration of enantiomer by 2D NOESY NMR.
出处 《化学研究与应用》 CAS CSCD 北大核心 2012年第12期1814-1818,共5页 Chemical Research and Application
基金 安徽省自然科学基金项目(1208085QB23)资助
关键词 恩替卡韦 对映异构体 高效液相色谱 手性控制 绝对构型 entecavir enantiomer HPLC chiral control absolute configuration
  • 相关文献

参考文献7

  • 1张明道,贾海浪,江荣英,方志杰.(S)-布林佐胺的合成及HPLC分析[J].化学研究与应用,2010,22(8):1075-1078. 被引量:7
  • 2Robert2, William S. Hydroxymethyl ( methylenecyclopen-tyl) purines and pyrimidines [ P]. EP: 0481754A2,1991-10-16.
  • 3Ziegler F, Sarpong M A. Radical cyclization studies direct-ed toward the synthesis of BMS-200475 entecavir : the car-bocyclic core[ J]. Tetrakednm,2003,59(45) :9013-9018.
  • 4Zhou B, Li Y-C. Synthesis of entecavir ( BMS-200475 )[J]. Tetrahedron Lett,2012,53(5) :502-504.
  • 5Catheiood N,Knudsen K R,Jorgensen K A. Enantioselec-tive synthesis of optically active carlx^ydrate sugars[ J].Org Chem,2001,66(3) :1014-1017.
  • 6BisacchiG S,Chao S T,Bachard C,et al. BMS-200475,anovel carfx)cyclic 2 , -deoxyguanosine analog with potentand selective anti-HBV activity in vitro[ J]. Bioorg MedChem Lett,1991 7(2) :127-132.
  • 7Bisacchi G S,Sundeen J E. Improved process for preparingthe antiviral agent entecavir [ P]. WO : 9809964Al. 1997-08-26.

二级参考文献7

  • 1Dean T R,Chen H H,May J A.Sulfonamides useful as carbonic anhydrase inhibitors[P].US:5 378 703,1995-01-03.
  • 2Conrow R E,Dean W D,Zinke P W,et al.Enantioselective synthesis of brinzolamide (AL-4862),a new topical carbonic anhydrase inhibitor.the "DCAT route" to thiophenesulfonamides[J].Org.Proc.Res.Dev.,1999,3 (2):114-120.
  • 3Sathe D G,Tarur R V,Bhise N B.Improved process for the preparation of (R)-(+) -4-(ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-2H-thieno[3,2-e] -1,2-thiazine-6-sulfonamide-1,1-dioxide[P].WO:2 008 062 463,2008-05-29.
  • 4Snieckus V.Directed ortho metalation.Tertiary amide and O-carbamate directors in synthetic strategies for polysubstituted aromatics[J].Chem.Rev.,1990,90,879-933.
  • 5Graham S L,Scholz T H.The reaction of sulfinic acid salts with hydroxylamine-O-sulfonic acid.a useful synthesis of primary sulfonamides[J].Synthesis,1986,(12):1031-1032.
  • 6DuPriest M T,Zinke P W,Conrow R E.Enantioselective synthesis of AL-4414A,a topically active carbonic anhydrase inhibitor[J].J.Org.Chem.,1997,62:9372-9375.
  • 7贾洪亮.抗青光眼药物的分类及其临床应用[J].现代诊断与治疗,2008,19(4):244-245. 被引量:13

共引文献6

同被引文献14

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部